Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 2, 2005, Pages 147-155

  Pilotto, A ^a   Franceschi, M ^a   Vitale, D F ^b   Zaninelli, A ^c   Masotti, G ^c   Rengo, F ^b,d  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; ACETIC ACID DERIVATIVE; AMTOLMETIN GUACIL; ANTACID AGENT; AURANOFIN; BENZYDAMINE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FLURBIPROFEN; GASTROINTESTINAL AGENT; GLUCOSAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MELOXICAM; NABUMETONE; NAPROXEN; NIFLUMIC ACID; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PIROXICAM; PROGLUMETACIN; PROTON PUMP INHIBITOR; ROFECOXIB; TENOXICAM; UNINDEXED DRUG;

ABDOMINAL PAIN; AGE DISTRIBUTION; AGED; AMBULATORY CARE; ANALGESIA; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ELDERLY CARE; EVALUATION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GENDER; GENERAL PRACTITIONER; HOSPITALIZATION; HUMAN; INDIGESTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY; UPPER GASTROINTESTINAL TRACT; VOMITING;

AGED; AMBULATORY CARE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; FAMILY PRACTICE; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HUMANS; MALE; PRESCRIPTIONS, DRUG; RANDOM ALLOCATION;

EID: 22844442802     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02537.x     Document Type: Article

References (24)

1. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-8.
2. Lapane KL, Spooner JJ, Mucha L, Straus WL. Effect of nonsteroidal antiinflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care. J Am Geriatr Soc 2001; 49: 577-84.
3. Pilotto A, Franceschi M, Leandro G, Di Mario F: Geriatric Gastroenterology Study Group (Società Italiana Gerontologia Geriatria). NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies. Drugs Aging 2003; 20: 701-10.
4. Lisse J, Espinoza L, Zhao SZ et al. Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib. J Gerontol A Biol Med Sci 2001; 56: M167-75.
5. Mamdani M, Rochon P, Juurlink DN, et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ 2002; 325: 624-9.
6. Goldstein JL, Sean Z, Zhao MD, et al. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen and naproxen in an insured population in the United States. Am J Gastroenterol 2003; 98: 2627-34.
7. Laine L, Wogen J, Yu H. Gastrointestinal health care resource utilization with chronic use of COX-2 specific inhibitors versus traditional NSAIDs. Gastroenterology 2003; 125: 389-95.
8. Katz S, Downs TD, Cash HR, Grotz RC. Progress in the development of an index of ADL. Gerontologist 1970; 10: 20-30.
9. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969: 9: 179-86.
10. Dimenas E, Glise H, Hallerback B et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroentrol 1995; 30: 1046-52.
11. L'informatore farmaceutico 2002. OEMF International, Milano 2002. Guidelines for ATC-Classification. Uppsala: NLN-publication No. 16 Nordic Council on Medicines, 1985.
12. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the gastrointestinal symptoms rating scale (GSRS) in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7: 75-83.
13. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 2002; 287: 337-44.
14. Linjakumpu T, Hartikainen S, Klaukka T et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002; 55: 809-17.
15. Lernfelt B, Samuelsson O, Skoog I, Landahl S. Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 2003; 59: 637-44.
16. Mannoni A, Briganti MP, Di Bari M et al. Epidemiological profile of symptomatic osteoarthritis in older adults: a population-based study in Dicomano, Italy. Ann Rheum Dis 2003; 62: 576-8.
17. Talley NJ, Evans JM, Fleming KC et al. Nonsteroidal anti-inflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995; 40: 1345-50.
18. Thomas J, Straus WL, Bloom BS. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Am J Gastroenterol 2002; 97: 2215-9.
19. Goldstein JL, Eisen GM, Burke T et al. Dyspepsia tolerability from the patients perspective: a comparison of celecoxib with diclofenac. Aliment Pharmacol Ther 2002; 16: 819-27.
20. Watson DJ, Harper SE, Zhao P et al. Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis. Arch Intern Med 2000; 160: 2998-3003.
21. Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ 2002; 325: 619-27.
22. Pilotto A, Franceschi M, Leandro G et al. Proton pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal antiinflammatory drugs. Aliment Pharmacol Ther 2004; 20: 1091-7.
23. Pilotto A, Franceschi M, Leandro G et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs. Aging Clin Exp Res 2003; 15: 494-9.
24. Pertusi RM, Godwin KS, House JK et al. Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners. J Am Osteopath Assoc 1999; 99: 305-10.